Novartis India case to resume on Monday
The case Novartis is bringing challenging the legality of certain provisions in the Indian Patent Act will resume on Monday, after it had been adjourned following an illness suffered by the judge. In the meantime, it seems, the pharmaceutical…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.